Mr. Kim has over 25 years' experience in global pharmaceutical commercialization. His therapeutic
experience includes infectious diseases, oncology and hospital medical devices ranging from wound care
to aesthetic products. He has worked with senior executives and scientists at Roche, Pfizer and Novartis,
developing a unique strategic approach to therapeutic franchise development with over $1B in investment.
He has led commercial and scientif

Mr. Farzetta has a broad and extensive career of over thirty years in the pharmaceutical industry
including tenure with major pharmaceutical companies Novartis, Fisons (now UCB) and Alpharma. He
is experienced in multiple dosage forms, drug delivery technologies and commercial operations. This
product and market knowledge is coupled with a broad based knowledge of commercial development that
includes numerous transactions including product ac

Ilsoon Yang brings a breadth of analytical and strategic expertise to COHENMedical, with past
experiences in the financial services and pharmaceutical industries. She has demonstrated success in
business strategy development and risk management through profit and loss forecast, portfolio
performance analysis, test development and analysis, and segmentation development to optimize risk and
return trade-offs.
Previous to her most recent role a

Dr. Cohen received his Bachelor and Master of Science d e g r e e s from the City University of New York and
his Ph.D. from the University of Massachusetts School of Medicine. He did his postdoctoral fellowship at
Ciba-Geigy Corporation, Summit, NJ and Horsham, UK. Dr. Cohen spent nearly 20 years in cardiovascular
drug discovery research as a Principal and Distinguished Fellow. He led groups that were instrumental in the
development of five m